Harpoon Therapeutics, Inc. (HARP) Retained Earnings (Accumulated Deficit) USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Harpoon Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2023.
  • Harpoon Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2023 was -$365 M, a 9.13% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 -$365 M -$30.5 M -9.13% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$363 M -$40.3 M -12.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$364 M -$58.7 M -19.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$353 M -$67.7 M -23.8% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 -$334 M -$70.9 M -26.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$322 M -$75.9 M -30.8% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 -$305 M -$75.3 M -32.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$285 M -$117 M -69.4% Dec 31, 2021 10-K 2023-03-27
Q3 2021 -$263 M -$107 M -68% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 -$247 M -$103 M -71.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$230 M -$99.1 M -75.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$168 M -$49.9 M -42.2% Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$157 M -$52.8 M -50.8% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 -$143 M -$55.4 M -63% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$131 M -$54.5 M -71.6% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 -$118 M -$55.6 M -88.8% Dec 31, 2019 10-K 2021-03-10
Q3 2019 -$104 M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$88 M Jun 30, 2019 10-Q 2019-08-05
Q1 2019 -$76.2 M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$62.6 M -$27.4 M -77.7% Dec 31, 2018 10-K 2020-03-12
Q4 2017 -$35.2 M Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.